Clinical Trials on Chronic Hepatitis C (CHC) in Switzerland
Total 50 results
-
Pevion Biotech LtdCompleted
-
Bristol-Myers SquibbBasel Institute of Clinical Epidemiology (BICE)Completed
-
University Hospital, Basel, SwitzerlandCompleted
-
University of BernRoche Pharma AG; University of Lausanne; University of Basel; Cantonal Hospital... and other collaboratorsCompleted
-
University Hospital, GenevaCompletedChronic Hepatitis CSwitzerland
-
University Hospital, GenevaGastaldi Giacomo; Clément SophieCompleted
-
Kantonsspital OltenCompletedPulmonary Artery Hypertension | Chronic Hepatitis cSwitzerland
-
AbbVieCompleted
-
University of ZurichPD Dr. rer. nat. Mathias HeikenwälderUnknown
-
Janssen Pharmaceutica N.V., BelgiumCompletedHepatitis, ChronicFrance, United Kingdom, Belgium, Germany, Netherlands, Switzerland
-
Boehringer IngelheimCompletedHepatitis C, ChronicFrance, Germany, Switzerland
-
Kirby InstituteMerck Sharp & Dohme LLCCompletedHepatitis C, ChronicAustralia, Canada, United Kingdom, Belgium, Germany, Norway, Switzerland
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
-
AbbVieCompletedHepatitis CAustria, Belgium, France, Greece, Israel, Italy, Poland, Portugal, Switzerland
-
Bristol-Myers SquibbCompletedHepatitis CAustralia, France, Germany, Italy, United Kingdom, United States, Canada, Poland, Austria, Denmark, Israel, Spain, Russian Federation, Switzerland, Argentina, Brazil
-
Janssen-Cilag International NVNo longer availableHepatitis CAustralia, Belgium, Germany, Spain, Switzerland, Romania, Serbia, Greece, New Zealand, Brazil, Russian Federation, Austria, Hungary, Czech Republic, Luxembourg
-
Kirby InstituteCompletedHepatitis C, ChronicUnited States, United Kingdom, Australia, France, New Zealand, Canada, Switzerland, Germany
-
Janssen Infectious Diseases BVBAVertex Pharmaceuticals IncorporatedCompletedHepatitis C, ChronicUnited States, Australia, United Kingdom, Germany, France, Spain, Belgium, Netherlands, Canada, Brazil, Puerto Rico, Poland, Sweden, Switzerland, Israel
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Australia, Austria, France, Germany, New Zealand, Portugal, Romania, Spain, Switzerland
-
University of OxfordGlaxoSmithKline; Cantonal Hospital of St. Gallen; St. James's Hospital, Ireland; ReiThera SrlCompletedHepatitis C InfectionSwitzerland, Ireland
-
Hoffmann-La RocheCompletedHepatitis C, ChronicBelgium, France, Germany, Italy, Spain, Sweden, United States, Greece, Portugal, Turkey, Switzerland, Canada, United Kingdom, Brazil
-
Hoffmann-La RocheCompletedHepatitis C, ChronicBelgium, United States, Germany, Canada, Austria, Switzerland, Puerto Rico, Australia, Brazil, Mexico
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Austria, Belgium, Canada, France, Germany, Japan, Portugal, Puerto Rico, Spain, Switzerland, United Kingdom
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Brazil, France, Germany, Italy, Spain, Switzerland, United Kingdom
-
Tibotec BVBATibotec Pharmaceutical LimitedCompletedHepatitis C, ChronicUnited States, Australia, France, United Kingdom, Germany, Spain, Belgium, Israel, Canada, Brazil, Austria, Poland, Netherlands, Sweden, Switzerland, Puerto Rico
-
Hoffmann-La RocheCompletedHepatitis C, ChronicBelgium, France, Germany, Sweden, Switzerland, Turkey, Greece, Taiwan, Estonia, Slovakia, Italy, Romania, Lithuania, Serbia, Portugal, Egypt, Pakistan, Mexico, Peru, Lebanon, United States, Argentina, Chile, Kuwait, Latvia, Macedonia, The... and more
-
Hoffmann-La RocheCompletedHepatitis C, ChronicBelgium, France, Germany, Sweden, Switzerland, Turkey, Greece, Ireland, Taiwan, Estonia, Hungary, Italy, Romania, United Kingdom, Serbia, Morocco, Portugal, Saudi Arabia, Egypt, Pakistan, Lebanon, Macedonia, The Former Yugoslav Republic... and more
-
University Hospital, Basel, SwitzerlandTerminated
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Argentina, Australia, Austria, Canada, Czech Republic, France, Germany, Korea, Republic of, Netherlands, Portugal, Romania, Spain, Switzerland, United Kingdom
-
University of ZurichCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionSpain, Switzerland, United Kingdom
-
Cytheris SAUnknownHepatitis CFrance, Switzerland, Italy
-
Cytheris SACompletedHepatitis CFrance, Switzerland, Italy
-
Novartis PharmaceuticalsTerminatedHepatitis C | Liver TransplantUnited States, Switzerland
-
Gilead SciencesCompletedChronic HCV InfectionBelgium, Austria, New Zealand, United Kingdom, Germany, Spain, Netherlands, France, Switzerland, Canada, Australia, Italy
-
Bristol-Myers SquibbCompletedHepatitis C VirusUnited States, Germany, Italy, Korea, Republic of, Sweden, Russian Federation, Canada, France, Argentina, Switzerland, Denmark, Taiwan, Netherlands, Spain, Mexico
-
Bristol-Myers SquibbCompletedHepatitis C VirusBelgium, Germany, Spain, United States, Canada, Brazil, Austria, France, Israel, Switzerland, Italy, Russian Federation, Czechia, Poland, United Kingdom
-
AbbVieCompletedHepatitis C Virus InfectionUnited States, Australia, Canada, China, Germany, Korea, Republic of, New Zealand, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Fondazione Epatocentro TicinoRecruiting
-
Hoffmann-La RocheCompletedChronic Hepatitis BChina, Korea, Republic of, Taiwan, Germany, United States, Singapore, Switzerland, Canada, Puerto Rico, Thailand, Israel, France, New Zealand, Poland, United Kingdom, Brazil, Australia
-
Novartis PharmaceuticalsCompletedLiver Transplantation | Hepatitis CSpain, Germany, Switzerland, Italy, United States, Korea, Republic of, Canada, Colombia, Belgium, Brazil, France, United Kingdom, Russian Federation
-
Boehringer IngelheimCompletedHepatitis CAustria, Belgium, France, Germany, Japan, Portugal, Romania, Russian Federation, Spain, Switzerland, United Kingdom
-
Boehringer IngelheimCompletedHepatitis CUnited States, Austria, Belgium, Canada, France, Germany, Japan, Korea, Republic of, Portugal, Romania, Russian Federation, Spain, Switzerland, Taiwan, United Kingdom
-
Janssen R&D IrelandCompletedHepatitis CUnited States, Australia, France, Poland, United Kingdom, Germany, Spain, Belgium, Israel, Portugal, Bulgaria, Romania, Denmark, Greece, Sweden, Canada, Czech Republic, Argentina, Brazil, Austria, Hungary, Switzerland, Puerto Rico, No...
-
Novartis PharmaceuticalsActive, not recruitingAutoimmune HepatitisUnited States, Belgium, Germany, United Kingdom, Spain, Switzerland, Argentina, Canada, Japan, Czechia
-
Kirby InstituteCompletedHepatitis CAustralia, United States, United Kingdom, New Zealand, Switzerland, Canada, Germany, Netherlands
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Rigshospitalet, DenmarkUniversity College, LondonEnrolling by invitationEnd Stage Liver Disease | Cardiovascular Diseases | Fractures, Bone | Diabetes Mellitus | Renal Insufficiency | Hepatitis B | Hepatitis C | Kidney Failure, Chronic | Proteinuria | HIV | Coinfection | Acidosis, Lactic | AIDSSpain, Switzerland, Germany, United Kingdom, Austria, Sweden, Finland, Israel, Denmark, France, Italy, Iceland, Belgium, Slovakia, Norway, Lithuania, Portugal, Poland, Croatia, Czechia, Greece, Hungary, Luxembourg, Argentina, Belarus, Bosnia... and more
-
Novartis PharmaceuticalsCompletedChronic Heart Failure (CHF)Spain, Croatia, Taiwan, Germany, Italy, United States, Australia, Netherlands, Switzerland, Belgium, United Kingdom, Bulgaria, Lithuania, Russian Federation, France, Argentina, Korea, Republic of, Poland, Canada, Turkey